In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
The closing price of DocGo Inc (NASDAQ: DCGO) was $3.62 for the day, up 0.28% from the previous closing price of $3.61. In other words, the price has increased by $0.28 from its previous closing price. On the day, 0.77 million shares were traded. DCGO stock price reached its highest trading level at $3.7 during the session, while it also had its lowest trading level at $3.545.
Ratios:
Our analysis of DCGO’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 1.99 and its Current Ratio is at 1.99. In the meantime, Its Debt-to-Equity ratio is 0.15 whereas as Long-Term Debt/Eq ratio is at 0.05.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, BTIG Research on August 18, 2023, initiated with a Buy rating and assigned the stock a target price of $15.
On April 21, 2023, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $11.
On April 19, 2022, Deutsche Bank started tracking the stock assigning a Buy rating and target price of $11.Deutsche Bank initiated its Buy rating on April 19, 2022, with a $11 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 15 ’24 when KATZ STEVEN bought 13,500 shares for $3.64 per share. The transaction valued at 49,140 led to the insider holds 69,534 shares of the business.
ROSENBERG NORMAN bought 10,000 shares of DCGO for $36,100 on Mar 14 ’24. The CFO and Treasurer now owns 274,222 shares after completing the transaction at $3.61 per share. On Mar 14 ’24, another insider, Burdiek Michael J, who serves as the Director of the company, bought 10,000 shares for $3.61 each. As a result, the insider paid 36,100 and bolstered with 571,595 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DCGO now has a Market Capitalization of 377099008 and an Enterprise Value of 368687456. As of this moment, DocGo’s Price-to-Earnings (P/E) ratio for their current fiscal year is 55.78, and their Forward P/E ratio for the next fiscal year is 9.64. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.80. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.60 while its Price-to-Book (P/B) ratio in mrq is 1.25. Its current Enterprise Value per Revenue stands at 0.591 whereas that against EBITDA is 11.611.
Stock Price History:
The Beta on a monthly basis for DCGO is 0.93, which has changed by -0.5558282 over the last 52 weeks, in comparison to a change of 0.24191546 over the same period for the S&P500. Over the past 52 weeks, DCGO has reached a high of $10.82, while it has fallen to a 52-week low of $2.78. The 50-Day Moving Average of the stock is -2.29%, while the 200-Day Moving Average is calculated to be -34.92%.
Shares Statistics:
DCGO traded an average of 1.04M shares per day over the past three months and 673730 shares per day over the past ten days. A total of 104.06M shares are outstanding, with a floating share count of 86.49M. Insiders hold about 16.97% of the company’s shares, while institutions hold 46.76% stake in the company. Shares short for DCGO as of 1713139200 were 9260441 with a Short Ratio of 8.91, compared to 1710460800 on 9906124. Therefore, it implies a Short% of Shares Outstanding of 9260441 and a Short% of Float of 10.190000000000001.
Earnings Estimates
The current rating of DocGo Inc (DCGO) is the result of assessments by 7.0 analysts actively engaged in evaluating its market dynamics.On average, analysts expect EPS of $0.08 for the current quarter, with a high estimate of $0.11 and a low estimate of $0.05, while EPS last year was -$0.03. The consensus estimate for the next quarter is $0.08, with high estimates of $0.11 and low estimates of $0.04.
Analysts are recommending an EPS of between $0.46 and $0.15 for the fiscal current year, implying an average EPS of $0.32. EPS for the following year is $0.4, with 5.0 analysts recommending between $0.58 and $0.17.
Revenue Estimates
It is expected that $90B in revenue will be generated in the current quarter, according to 7 analysts. It ranges from a high estimate of $202.9M to a low estimate of $181.52M. As of the current estimate, DocGo Inc’s year-ago sales were $111.53MFor the next quarter, 7 analysts are estimating revenue of $181.28M. There is a high estimate of $206.3M for the next quarter, whereas the lowest estimate is $162.08M.
A total of 7 analysts have provided revenue estimates for DCGO’s current fiscal year. The highest revenue estimate was $776.1M, while the lowest revenue estimate was $687.1M, resulting in an average revenue estimate of $725.19M. In the same quarter a year ago, actual revenue was $624.29MBased on 5 analysts’ estimates, the company’s revenue will be $734.92M in the next fiscal year. The high estimate is $825.24M and the low estimate is $680.46M.
